Advertisement
Canada markets open in 8 hours 30 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7305
    +0.0007 (+0.09%)
     

  • CRUDE OIL

    82.89
    +0.08 (+0.10%)
     

  • Bitcoin CAD

    88,060.48
    -3,697.77 (-4.03%)
     

  • CMC Crypto 200

    1,389.38
    -34.72 (-2.44%)
     

  • GOLD FUTURES

    2,327.40
    -11.00 (-0.47%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,452.25
    -212.25 (-1.20%)
     

  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    37,712.47
    -747.61 (-1.94%)
     

  • CAD/EUR

    0.6818
    -0.0001 (-0.01%)
     

Interview with Emerald Health Therapeutics - VP Bernie Hertel Talks Pure Sunfarms JV and Expanding Operations

Newsfile Corp.

Toronto, Ontario--(Newsfile Corp. - October 11, 2019) - Capital 10X President Evan Veryard sits down with Emerald Health Therapeutics (TSXV: EMH) (OTCQX: EMHTF) VP of Finance and Communications Bernie Hertel.



Cannot view this video? Visit:
https://capital10x.com/interview-emerald-health-therapeutics-sunfarms-jv-expanding-operations/

Mr. Hertel provides an overview of Emerald Health Therapeutics; a Canadian licensed producer of cannabis products led by a team of life science professionals. He details their "defined dose" approach to developing differentiated products for medical- and adult-use customers.

ADVERTISEMENT

This is followed by a discussion of the impressive financial results of their Pure SunFarms JV, expanding operations, new c-suite additions, and upcoming catalysts.

For more information about this interview, please contact:

Capital 10X
Evan Veryard, President
416-571-9037

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/48700